Udagawa, T.
393  results:
Search for persons X
?
2

Safety and efficacy of first-line nivolumab plus chemothera..:

Shimozaki, K. ; Fukuda, K. ; Ooki, A....
ESMO Gastrointestinal Oncology.  5 (2024)  - p. 100072 , 2024
 
?
3

P2.10-02 Liquid Biopsy-based Umbrella Trial for Advanced NS..:

Nakatani, Y. ; Nosaki, K. ; Sugimoto, A....
Journal of Thoracic Oncology.  18 (2023)  11 - p. S352 , 2023
 
?
 
?
6

EP08.02-113 Clinico-genomic Characteristics of Patients wit..:

Okahisa, M. ; Udagawa, H. ; Matsumoto, S....
Journal of Thoracic Oncology.  17 (2022)  9 - p. S455-S456 , 2022
 
?
7

Supplementary Material for: Lack of Increased Risk of Lymph..:

Kobayashi T. (4274560) ; Udagawa E. (11900675) ; Hibi T. (4606375)
https://figshare.com/articles/dataset/Supplementary_Material_for_Lack_of_Increased_Risk_of_Lymphoma_with_Thiopurine_Therapy_Regardless_of_Dose_and_Duration_of_Treatment_in_Japanese_Patients_with_Inflammatory_Bowel_Diseases/17805485.  , 2022
 
?
 
?
 
?
13

Imaging alloreactive T cells provides early warning of orga..:

Hirai, Toshihito ; Mayer, Aaron T ; Nobashi, Tomomi W...
info:eu-repo/semantics/altIdentifier/doi/10.1172/jci.insight.145360.  , 2021
 
1-15